Cargando…

Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry

BACKGROUND: Little is known on the characteristics of patients diagnosed with idiopathic pulmonary fibrosis (IPF) in Spain. We aimed to characterize the demographic and clinical profile of IPF patients included in the IPF National Registry of the Spanish Respiratory Society (SEPAR). METHODS: This is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Fabrellas, Estrella, Molina-Molina, María, Soriano, Joan B., Portal, José Antonio Rodríguez, Ancochea, Julio, Valenzuela, Claudia, Xaubet, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580511/ https://www.ncbi.nlm.nih.gov/pubmed/31208406 http://dx.doi.org/10.1186/s12931-019-1084-0

Ejemplares similares

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
por: Fernández Fabrellas, Estrella, et al.
Publicado: (2018)

Face Mask Exemptions, Respiratory Patients, and COVID-19 in Spain. Data From the 2021 ITC EUREST-PLUS Spain Survey
por: Soriano, Joan B., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic in mortality due to respiratory diseases: A comparative analysis of 2021 and 2020 vs 2019 in Spain
por: Soriano, Joan B, et al.
Publicado: (2023)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Forecasting COVID-19 Infection Trends and New Hospital Admissions in Spain due to SARS-CoV-2 Variant of Concern Omicron
por: Soriano, Joan B., et al.
Publicado: (2022)

The Emergence of COVID-19 as a Cause of Death in 2020 and its Effect on Mortality by Diseases of the Respiratory System in Spain: Trends and Their Determinants Compared to 2019
por: Soriano, Joan B., et al.
Publicado: (2022)

Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt
por: Giménez, Alícia, et al.
Publicado: (2017)

Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis
por: Gabasa, Marta, et al.
Publicado: (2017)

Sobre la nueva condición post COVID-19
por: Soriano, Joan B., et al.
Publicado: (2021)

On the new post COVID-19 condition()
por: Soriano, Joan B., et al.
Publicado: (2021)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

The JAK2 pathway is activated in idiopathic pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2018)

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
por: Molina-Molina, Maria
Publicado: (2019)

Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective
por: Teoh, Alan K. Y., et al.
Publicado: (2020)

Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2020)

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document
por: Bouza, Emilio, et al.
Publicado: (2020)

Biomarkers of Fibrosis in Patients with COVID-19 One Year After Hospital Discharge: A Prospective Cohort Study
por: Mulet, Alba, et al.
Publicado: (2023)

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2019)

Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing
por: Izquierdo, Jose Luis, et al.
Publicado: (2020)

COVID-19 en jóvenes y la quinta ola
por: Soriano, Joan B., et al.
Publicado: (2022)

[Translated article] COVID-19 in Youth and the Fifth Wave
por: Soriano, Joan B., et al.
Publicado: (2022)

National Rare Disease Registries: overview from Spain
por: de la Paz, M Posada, et al.
Publicado: (2014)

The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target
por: Galán-Cobo, Ana, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes
por: Sauleda, Jaume, et al.
Publicado: (2018)

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
por: Alonso-Gonzalez, Aitana, et al.
Publicado: (2023)

Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2
por: Gabasa, Marta, et al.
Publicado: (2013)

National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR)
por: Alonso, Verónica, et al.
Publicado: (2014)

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2016)

Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic
por: Serra López-Matencio, José M., et al.
Publicado: (2021)

Face mask exemptions, psychiatric patients, and COVID-19
por: Ayuso-Mateos, José Luis, et al.
Publicado: (2020)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018)

The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
por: Ryerson, Christopher J., et al.
Publicado: (2016)

Epidemiology of Sarcoidosis
por: Fabrellas, Estrella Fernández
Publicado: (2007)

Epidemiología de la sarcoidosis
por: Fernández Fabrellas, Estrella
Publicado: (2007)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Mitochondrial Dysfunction in Lung Resident Mesenchymal Stem Cells from Idiopathic Pulmonary Fibrosis Patients
por: Mercader-Barceló, Josep, et al.
Publicado: (2023)

Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosis
por: Popper, Helmut, et al.
Publicado: (2021)

Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis
por: Maldonado, Mariel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_emm9vc843nrndbhkaspmump0vl